C Kahl

Summary

Affiliation: University of Rostock
Country: Germany

Publications

  1. doi request reprint Multimodal therapy for localized spinal epidural follicular lymphoma
    Christoph Kahl
    Department of Internal Medicine, Division of Hematology and Oncology, University of Rostock, Germany
    Onkologie 33:381-4. 2010
  2. doi request reprint [Pancytopenia and lymph node swelling. Cardinal symptoms of an unusual differential diagnosis]
    C Kahl
    Abteilung Hämatologie und Onkologie, Klinik und Poliklinik für Innere Medizin, Ernst Heydemann Strasse 6, 18055 Rostock
    Internist (Berl) 50:734-9. 2009
  3. ncbi request reprint [Differential diagnosis of a macrocytic, hyperchromic anemia following alcohol abuse and simultaneous therapy with triamterene and cotrimoxazole]
    C Kahl
    Abteilung Hämatologie und Onkologie, Klinik und Poliklinik für Innere Medizin, Universitat Rostock
    Dtsch Med Wochenschr 130:2139-41. 2005
  4. ncbi request reprint Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation
    C Kahl
    Division of Hematology and Oncology, Department of Internal Medicine, University of Rostock, Ernst Heydemann Str 6, 18055 Rostock, Germany
    Ann Hematol 81:646-50. 2002
  5. ncbi request reprint Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease
    D Wolff
    Department of Haematology and Oncology, University of Rostock, Rostock, Germany
    Bone Marrow Transplant 38:445-51. 2006
  6. doi request reprint Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation
    M Leithauser
    Department of Medicine, Division of Hematology Oncology, University of Rostock, Rostock, Germany
    Transpl Infect Dis 12:251-7. 2010
  7. ncbi request reprint Treatment with campath-1H for relapsed chronic lymphocytic leukemia after allogeneic peripheral blood stem cell transplantation does not abrogate the development of chronic GVHD
    Daniel Wolff
    Division of Haematology and Oncology, Department of Internal Medicine, University of Rostock, Germany
    Eur J Haematol 72:145-8. 2004
  8. ncbi request reprint [Allogeneic blood stem cell transplantation in high-risk patients after conditioning with treosulfan and fludarabine]
    J Casper
    Abteilung Hämatologie und Onkologie der Medizinischen Fakultät der Universität Rostock
    Dtsch Med Wochenschr 130:2125-9. 2005
  9. ncbi request reprint [Rational therapy with hematopoetic growth factors (G-CSF, GM-CSF) for patients in neutropenia]
    C Kahl
    Abteilung Hämatologie und Onkologie, Klinik und Poliklinik für Innere Medizin, Universitat Rostock, Germany
    Dtsch Med Wochenschr 127:1473-8. 2002
  10. ncbi request reprint Progressive interstitial fibrosis of the lung in sclerodermoid chronic graft-versus-host disease
    D Wolff
    Division of Hematology and Oncology, Department of Internal Medicine, University of Rostock, Germany
    Bone Marrow Transplant 29:357-60. 2002

Detail Information

Publications12

  1. doi request reprint Multimodal therapy for localized spinal epidural follicular lymphoma
    Christoph Kahl
    Department of Internal Medicine, Division of Hematology and Oncology, University of Rostock, Germany
    Onkologie 33:381-4. 2010
    ..An epidural growth of low-grade lymphoma is even more unusual. Due to this low incidence, therapeutic experience for this entity is limited...
  2. doi request reprint [Pancytopenia and lymph node swelling. Cardinal symptoms of an unusual differential diagnosis]
    C Kahl
    Abteilung Hämatologie und Onkologie, Klinik und Poliklinik für Innere Medizin, Ernst Heydemann Strasse 6, 18055 Rostock
    Internist (Berl) 50:734-9. 2009
    ..This therapy resulted in normalization of the blood counts. Anitibody levels and the EBV genome levels became negative...
  3. ncbi request reprint [Differential diagnosis of a macrocytic, hyperchromic anemia following alcohol abuse and simultaneous therapy with triamterene and cotrimoxazole]
    C Kahl
    Abteilung Hämatologie und Onkologie, Klinik und Poliklinik für Innere Medizin, Universitat Rostock
    Dtsch Med Wochenschr 130:2139-41. 2005
    ..Skin and mucosa were pale, she denied major infections or bleedings. An alcohol abuse was known for many years. Because of edema she received a therapy with triamteren, an infection of the urinary tract was treated with cotrimoxacol...
  4. ncbi request reprint Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation
    C Kahl
    Division of Hematology and Oncology, Department of Internal Medicine, University of Rostock, Ernst Heydemann Str 6, 18055 Rostock, Germany
    Ann Hematol 81:646-50. 2002
    ..Because of the poor outcome of these patients after conventional chemotherapy, HDCT seems to be a rational option in first-line therapy. Whether it improves survival in these patients should be further investigated...
  5. ncbi request reprint Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease
    D Wolff
    Department of Haematology and Oncology, University of Rostock, Rostock, Germany
    Bone Marrow Transplant 38:445-51. 2006
    ..Our data demonstrate that replacement of CI by daclizumab can improve TAM and RI. However, mortality remains high in patients with acute GVHD...
  6. doi request reprint Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation
    M Leithauser
    Department of Medicine, Division of Hematology Oncology, University of Rostock, Rostock, Germany
    Transpl Infect Dis 12:251-7. 2010
    ..Despite effective antifungals and surgical intervention, the prognosis is grim in patients with active GVHD, as immunoreconstitution is mandatory for successful management...
  7. ncbi request reprint Treatment with campath-1H for relapsed chronic lymphocytic leukemia after allogeneic peripheral blood stem cell transplantation does not abrogate the development of chronic GVHD
    Daniel Wolff
    Division of Haematology and Oncology, Department of Internal Medicine, University of Rostock, Germany
    Eur J Haematol 72:145-8. 2004
    ..Furthermore, the GVL effect was not abrogated by the use of campath-1H...
  8. ncbi request reprint [Allogeneic blood stem cell transplantation in high-risk patients after conditioning with treosulfan and fludarabine]
    J Casper
    Abteilung Hämatologie und Onkologie der Medizinischen Fakultät der Universität Rostock
    Dtsch Med Wochenschr 130:2125-9. 2005
    ..We have, therefore, developed a dose intense but toxicity reduced conditioning regimen based on treosulfan and fludarabine and report first results...
  9. ncbi request reprint [Rational therapy with hematopoetic growth factors (G-CSF, GM-CSF) for patients in neutropenia]
    C Kahl
    Abteilung Hämatologie und Onkologie, Klinik und Poliklinik für Innere Medizin, Universitat Rostock, Germany
    Dtsch Med Wochenschr 127:1473-8. 2002
  10. ncbi request reprint Progressive interstitial fibrosis of the lung in sclerodermoid chronic graft-versus-host disease
    D Wolff
    Division of Hematology and Oncology, Department of Internal Medicine, University of Rostock, Germany
    Bone Marrow Transplant 29:357-60. 2002
    ..While one patient responded to increased immunosuppression including total nodal irradiation (1 Gy), the other patient died due to complications related to pulmonary fibrosis...
  11. ncbi request reprint Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO)
    M Sandherr
    Medizinische Klinik, Klinikum Augsburg, Germany
    Ann Oncol 17:1051-9. 2006
    ..The objective of this guideline is to review the basis of prophylactic strategies and to provide recommendations for clinicians treating patients with haematological malignancies and solid tumors...
  12. ncbi request reprint Ifosamide, epirubicin and granulocyte colony-stimulating factor: a regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma
    M Arland
    Division of Medicine, Klinikum Fulda, Germany
    Hematol Oncol 19:59-66. 2001
    ....